Cargando…
Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelone: Study protocol for a randomized controlled trial
INTRODUCTION: Utidelone (UTD1) is a new chemotherapeutic drug for recurrent or metastatic breast cancer. However, it usually leads to severe peripheral neuropathy (PN) and causes numbness of the hands and feet and significant pain in patients' life. Electroacupuncture (EA) is considered benefic...
Autores principales: | Lu, Chao, Li, Guangliang, Deng, Dehou, Li, Rongrong, Li, Xiaoyu, Feng, Xukang, Wu, Taoping, Shao, Xiying, Chen, Weiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946987/ https://www.ncbi.nlm.nih.gov/pubmed/36846114 http://dx.doi.org/10.3389/fneur.2023.1065635 |
Ejemplares similares
-
Efficacy of electroacupuncture with different frequencies in the treatment of chemotherapy-induced peripheral neuropathy: A study protocol for a randomized controlled trial
por: Lu, Chao, et al.
Publicado: (2022) -
Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial
por: Xu, Junnan, et al.
Publicado: (2020) -
Utidelone inhibits growth of colorectal cancer cells through ROS/JNK signaling pathway
por: Li, Fuli, et al.
Publicado: (2021) -
Light-Chain Amyloidosis With Peripheral Neuropathy as an Initial Presentation
por: Qian, Min, et al.
Publicado: (2021) -
Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
por: Zhang, Pin, et al.
Publicado: (2016)